title: 16S rRNA terminal restriction fragment length polymorphism for the characterization of the nasopharyngeal microbiota.
abstract: A novel non-culture based 16S rRNA Terminal Restriction Fragment Length Polymorphism (T-RFLP) method using the restriction enzymes Tsp509I and Hpy166II was developed for the characterization of the nasopharyngeal microbiota and validated using recently published 454 pyrosequencing data. 16S rRNA gene T-RFLP for 153 clinical nasopharyngeal samples from infants with acute otitis media (AOM) revealed 5 Tsp509I and 6 Hpy166II terminal fragments (TFs) with a prevalence of >10%. Cloning and sequencing identified all TFs with a prevalence >6% allowing a sufficient description of bacterial community changes for the most important bacterial taxa. The conjugated 7-valent pneumococcal polysaccharide vaccine (PCV-7) and prior antibiotic exposure had significant effects on the bacterial composition in an additive main effects and multiplicative interaction model (AMMI) in concordance with the 16S rRNA 454 pyrosequencing data. In addition, the presented T-RFLP method is able to discriminate S. pneumoniae from other members of the Mitis group of streptococci, which therefore allows the identification of one of the most important human respiratory tract pathogens. This is usually not achieved by current high throughput sequencing protocols. In conclusion, the presented 16S rRNA gene T-RFLP method is a highly robust, easy to handle and a cheap alternative to the computationally demanding next-generation sequencing analysis. In case a lot of nasopharyngeal samples have to be characterized, it is suggested to first perform 16S rRNA T-RFLP and only use next generation sequencing if the T-RFLP nasopharyngeal patterns differ or show unknown TFs.
authors.affiliation: Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
authors.forename: Silvio D
authors.initials: SD
authors.lastname: Brugger
authors.forename: Laurence
authors.initials: L
authors.lastname: Frei
authors.forename: Pascal M
authors.initials: PM
authors.lastname: Frey
authors.forename: Suzanne
authors.initials: S
authors.lastname: Aebi
authors.forename: Kathrin
authors.initials: K
authors.lastname: Mühlemann
authors.forename: Markus
authors.initials: M
authors.lastname: Hilty
mesh_terms: D000192:Actinomycetales / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D044007:Moraxellaceae / Q000235:genetics / Q000302:isolation & purification; D009305:Nasopharynx / Q000382:microbiology*; D015661:Pasteurellaceae / Q000235:genetics / Q000302:isolation & purification; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length / Q000235:genetics*; D012336:RNA, Ribosomal, 16S / Q000235:genetics*; D040141:Staphylococcaceae / Q000235:genetics / Q000302:isolation & purification; D013289:Streptococcaceae / Q000235:genetics / Q000302:isolation & purification
chemical_list: D012336:RNA, Ribosomal, 16S